Literature DB >> 2217958

Ankylosing spondylitis and other spondyloarthropathies.

M A Khan1, S M van der Linden.   

Abstract

Ankylosing spondylitis and related spondyloarthropathies show a remarkable association with a genetic marker--HLA-B27--and also illustrate the relationship between host and environmental factors. HLA-B27 has revitalized the epidemiology of spondyloarthropathies and has helped to broaden the clinical spectrum of these diseases. These and other aspects of descriptive and genetic epidemiology are reviewed.

Entities:  

Mesh：

Year:  1990        PMID： 2217958

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN： 0889-857X            Impact factor:   2.670


  19 in total

1.  Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?

Authors:  S Bas; C Scieux; T L Vischer
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  Spectrum of ankylosing spondylitis in Portugal. Development of BASDAI, BASFI, BASMI and mSASSS reference centile charts.

Authors:  Fernando M Pimentel-Santos; Ana Filipa Mourão; Célia Ribeiro; José Costa; Helena Santos; Anabela Barcelos; Patricia Pinto; Fátima Godinho; Margarida Cruz; Elsa Vieira-Sousa; Rui André Santos; Sara Rabiais; Jorge Félix; João Eurico Fonseca; Henrique Guedes-Pinto; Matthew A Brown; Jaime C Branco
Journal:  Clin Rheumatol       Date:  2011-10-19       Impact factor: 2.980

3.  Health-related quality of life outcomes in patients with rheumatoid arthritis and ankylosing spondylitis after tapering biologic treatment.

Authors:  Ming-Han Chen; Mei-Hsuan Lee; Hsien-Tzung Liao; Wei-Sheng Chen; Chien-Chih Lai; Chang-Youh Tsai
Journal:  Clin Rheumatol       Date:  2018-01-06       Impact factor: 2.980

Review 4.  Epidemiology of HLA-B27 and Arthritis.

Authors:  M A Khan
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

Review 5.  HLA-B27 and spondyloarthropathy: value for early diagnosis?

Authors:  J T Gran; G Husby
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

6.  Assessment of MRI abnormalities of the sacroiliac joints and their ability to predict axial spondyloarthritis: a retrospective pilot study on 110 patients.

Authors:  Ahmed Larbi; Pierre Viala; Nicolas Molinari; Cedric Lukas; Marie Pierre Baron; Patrice Taourel; Catherine Cyteval
Journal:  Skeletal Radiol       Date:  2014-01-03       Impact factor: 2.199

Review 7.  Impact of biological therapy on spondyloarthritis.

Authors:  Nicola Maruotti; Francesco Paolo Cantatore
Journal:  Eur J Clin Pharmacol       Date:  2014-06-10       Impact factor: 2.953

8.  Ankylosing spondylitis and undifferentiated spondyloarthritis in Kuwait: a comparison between Arabs and South Asians.

Authors:  S S Uppal; Mini Abraham; R I Chowdhury; Rakesh Kumari; E M Pathan; A Al Rashed
Journal:  Clin Rheumatol       Date:  2005-10-21       Impact factor: 2.980

9.  Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan.

Authors:  James Cheng-Chung Wei; Ruey-Hong Wong; Jun-Huang Huang; Chen-Tung Yu; Chung-Tei Chou; Ming-Shiou Jan; Gregory J Tsay; Ming-Chih Chou; Hong-Shen Lee
Journal:  Clin Rheumatol       Date:  2007-02-08       Impact factor: 2.980

10.  Ankylosing spondylitis. Current drug treatment.

Authors:  J T Gran; G Husby
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.